What caused the death of Aine Rose Hurst?

Aine Rose Hurst died from a blood clot in her brain, which was linked to her prescribed oral contraceptive pill, Femodette.

Why did Aine Hurst's family want more awareness about birth control pills?

Her family believes there is not enough awareness about the side-effects of birth control pills and called for clearer labeling and public education.

Was the birth control pill appropriately prescribed to Aine Hurst?

According to the Bolton GP Federation and the inquest's findings, the GP consulted with Aine Hurst in line with national medical eligibility guidance.

Home / Health / Teen's Death Spurs Call for Birth Control Pill Awareness

Teen's Death Spurs Call for Birth Control Pill Awareness

3 Feb

•

Summary

Aine Rose Hurst died from a brain blood clot linked to her birth control pill.
Her family advocates for greater awareness of oral contraceptive side-effects.
The GP Federation stated the medication was appropriately prescribed.

Teen's Death Spurs Call for Birth Control Pill Awareness

Aine Rose Hurst, aged 19, tragically died in March of the previous year due to a blood clot in her brain, a condition linked to her prescribed oral contraceptive pill, Femodette. Initially, Aine was removed from the pill due to high blood pressure discovered during her annual check-up. However, after her blood pressure normalized within NHS guidance, she was put back on the medication.

Her mother recounted Aine's final days, detailing a persistent headache that worsened significantly, leading to a desperate call for medical help. Despite attempts to consult a GP and contact emergency services, Aine suffered a fatal event. Doctors determined the blood clot was too large to operate on, and tragically, she passed away after being found to have no brain function.

Aine's aunt and mother have since spoken out, emphasizing a perceived lack of awareness regarding the side-effects of birth control. They highlighted the extensive patient information leaflets that often go unread, particularly by young women, and called for clearer packaging and increased public education on the potential risks associated with oral contraceptives.